(OMC) Omnicom - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US6819191064
Stock: Advertising, Marketing, Communications, Media, Public Relations
Total Rating 40
Risk 87
Buy Signal -0.03
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.72% |
| Yield on Cost 5y | 5.50% |
| Yield CAGR 5y | 0.88% |
| Payout Consistency | 96.7% |
| Payout Ratio | 34.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 31.3% |
| Relative Tail Risk | -3.55% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.23 |
| Alpha | -20.48 |
| Character TTM | |
|---|---|
| Beta | 0.693 |
| Beta Downside | 0.802 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.65% |
| CAGR/Max DD | -0.08 |
Description: OMC Omnicom January 04, 2026
Omnicom Group Inc. (NYSE: OMC) is a global holding company that delivers a full suite of advertising, marketing, and corporate communications services through its network of agencies. Its offerings span media planning and buying, precision and digital marketing, public relations, healthcare communications, experiential and retail commerce solutions, as well as data analytics and digital transformation consulting.
Key industry drivers for Omnicom include the ongoing shift toward programmatic media buying (which grew > 15 % YoY in 2023) and increasing client spend on data-driven, performance-based marketing-areas where Omnicom’s analytics and precision-marketing units have posted double-digit revenue growth. The firm reported FY 2023 revenue of $14.8 billion, with operating margins stabilizing near 13 % despite macro-headwinds in discretionary ad spend.
For a deeper, data-rich perspective on Omnicom’s valuation dynamics, consider exploring the detailed analyst toolkit on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 1.33b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.57 > 1.0 |
| NWC/Revenue: -7.79% < 20% (prev -1.66%; Δ -6.13% < -1%) |
| CFO/TA 0.06 > 3% & CFO 1.83b > Net Income 1.33b |
| Net Debt (3.64b) to EBITDA (2.45b): 1.49 < 3 |
| Current Ratio: 0.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (194.9m) vs 12m ago -1.66% < -2% |
| Gross Margin: 17.42% > 18% (prev 0.18%; Δ 1725 % > 0.5%) |
| Asset Turnover: 55.75% > 50% (prev 53.58%; Δ 2.17% > 0%) |
| Interest Coverage Ratio: 8.94 > 6 (EBITDA TTM 2.45b / Interest Expense TTM 247.1m) |
Altman Z'' 2.06
| A: -0.04 (Total Current Assets 15.19b - Total Current Liabilities 16.44b) / Total Assets 28.84b |
| B: 0.42 (Retained Earnings 11.98b / Total Assets 28.84b) |
| C: 0.08 (EBIT TTM 2.21b / Avg Total Assets 28.82b) |
| D: 0.45 (Book Value of Equity 10.69b / Total Liabilities 23.72b) |
| Altman-Z'' Score: 2.06 = BBB |
Beneish M -3.04
| DSRI: 0.96 (Receivables 8.59b/8.57b, Revenue 16.07b/15.43b) |
| GMI: 1.01 (GM 17.42% / 17.53%) |
| AQI: 1.00 (AQ_t 0.41 / AQ_t-1 0.41) |
| SGI: 1.04 (Revenue 16.07b / 15.43b) |
| TATA: -0.02 (NI 1.33b - CFO 1.83b) / TA 28.84b) |
| Beneish M-Score: -3.04 (Cap -4..+1) = AA |
What is the price of OMC shares?
As of February 01, 2026, the stock is trading at USD 77.04 with a total of 3,474,095 shares traded.
Over the past week, the price has changed by -3.45%, over one month by -4.57%, over three months by +3.67% and over the past year by -7.60%.
Over the past week, the price has changed by -3.45%, over one month by -4.57%, over three months by +3.67% and over the past year by -7.60%.
Is OMC a buy, sell or hold?
Omnicom has received a consensus analysts rating of 3.91.
Therefore, it is recommended to buy OMC.
- StrongBuy: 3
- Buy: 5
- Hold: 2
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the OMC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 101.1 | 31.2% |
| Analysts Target Price | 101.1 | 31.2% |
| ValueRay Target Price | 79 | 2.5% |
OMC Fundamental Data Overview January 28, 2026
P/E Trailing = 11.8525
P/E Forward = 8.643
P/S = 1.5874
P/B = 5.4801
P/EG = 16.3035
Revenue TTM = 16.07b USD
EBIT TTM = 2.21b USD
EBITDA TTM = 2.45b USD
Long Term Debt = 4.88b USD (from longTermDebt, last quarter)
Short Term Debt = 1.40b USD (from shortTermDebt, last quarter)
Debt = 7.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.64b USD (from netDebt column, last quarter)
Enterprise Value = 29.14b USD (25.50b + Debt 7.04b - CCE 3.41b)
Interest Coverage Ratio = 8.94 (Ebit TTM 2.21b / Interest Expense TTM 247.1m)
EV/FCF = 17.47x (Enterprise Value 29.14b / FCF TTM 1.67b)
FCF Yield = 5.72% (FCF TTM 1.67b / Enterprise Value 29.14b)
FCF Margin = 10.38% (FCF TTM 1.67b / Revenue TTM 16.07b)
Net Margin = 8.31% (Net Income TTM 1.33b / Revenue TTM 16.07b)
Gross Margin = 17.42% ((Revenue TTM 16.07b - Cost of Revenue TTM 13.27b) / Revenue TTM)
Gross Margin QoQ = 18.14% (prev 17.39%)
Tobins Q-Ratio = 1.01 (Enterprise Value 29.14b / Total Assets 28.84b)
Interest Expense / Debt = 0.86% (Interest Expense 60.4m / Debt 7.04b)
Taxrate = 26.85% (132.3m / 492.7m)
NOPAT = 1.62b (EBIT 2.21b * (1 - 26.85%))
Current Ratio = 0.92 (Total Current Assets 15.19b / Total Current Liabilities 16.44b)
Debt / Equity = 1.53 (Debt 7.04b / totalStockholderEquity, last quarter 4.61b)
Debt / EBITDA = 1.49 (Net Debt 3.64b / EBITDA 2.45b)
Debt / FCF = 2.18 (Net Debt 3.64b / FCF TTM 1.67b)
Total Stockholder Equity = 4.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.63% (Net Income 1.33b / Total Assets 28.84b)
RoE = 30.22% (Net Income TTM 1.33b / Total Stockholder Equity 4.42b)
RoCE = 23.77% (EBIT 2.21b / Capital Employed (Equity 4.42b + L.T.Debt 4.88b))
RoIC = 15.22% (NOPAT 1.62b / Invested Capital 10.62b)
WACC = 6.77% (E(25.50b)/V(32.54b) * Re(8.47%) + D(7.04b)/V(32.54b) * Rd(0.86%) * (1-Tc(0.27)))
Discount Rate = 8.47% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.16%
[DCF Debug] Terminal Value 84.25% ; FCFF base≈1.60b ; Y1≈1.82b ; Y5≈2.50b
Fair Price DCF = 169.1 (EV 56.83b - Net Debt 3.64b = Equity 53.19b / Shares 314.6m; r=6.77% [WACC]; 5y FCF grow 16.14% → 2.90% )
EPS Correlation: -20.44 | EPS CAGR: -43.62% | SUE: -4.0 | # QB: 0
Revenue Correlation: 60.62 | Revenue CAGR: 1.23% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.77 | Chg30d=-0.000 | Revisions Net=+1 | Analysts=4
EPS next Year (2026-12-31): EPS=9.93 | Chg30d=+0.178 | Revisions Net=-1 | Growth EPS=+18.4% | Growth Revenue=-0.7%
P/E Forward = 8.643
P/S = 1.5874
P/B = 5.4801
P/EG = 16.3035
Revenue TTM = 16.07b USD
EBIT TTM = 2.21b USD
EBITDA TTM = 2.45b USD
Long Term Debt = 4.88b USD (from longTermDebt, last quarter)
Short Term Debt = 1.40b USD (from shortTermDebt, last quarter)
Debt = 7.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.64b USD (from netDebt column, last quarter)
Enterprise Value = 29.14b USD (25.50b + Debt 7.04b - CCE 3.41b)
Interest Coverage Ratio = 8.94 (Ebit TTM 2.21b / Interest Expense TTM 247.1m)
EV/FCF = 17.47x (Enterprise Value 29.14b / FCF TTM 1.67b)
FCF Yield = 5.72% (FCF TTM 1.67b / Enterprise Value 29.14b)
FCF Margin = 10.38% (FCF TTM 1.67b / Revenue TTM 16.07b)
Net Margin = 8.31% (Net Income TTM 1.33b / Revenue TTM 16.07b)
Gross Margin = 17.42% ((Revenue TTM 16.07b - Cost of Revenue TTM 13.27b) / Revenue TTM)
Gross Margin QoQ = 18.14% (prev 17.39%)
Tobins Q-Ratio = 1.01 (Enterprise Value 29.14b / Total Assets 28.84b)
Interest Expense / Debt = 0.86% (Interest Expense 60.4m / Debt 7.04b)
Taxrate = 26.85% (132.3m / 492.7m)
NOPAT = 1.62b (EBIT 2.21b * (1 - 26.85%))
Current Ratio = 0.92 (Total Current Assets 15.19b / Total Current Liabilities 16.44b)
Debt / Equity = 1.53 (Debt 7.04b / totalStockholderEquity, last quarter 4.61b)
Debt / EBITDA = 1.49 (Net Debt 3.64b / EBITDA 2.45b)
Debt / FCF = 2.18 (Net Debt 3.64b / FCF TTM 1.67b)
Total Stockholder Equity = 4.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.63% (Net Income 1.33b / Total Assets 28.84b)
RoE = 30.22% (Net Income TTM 1.33b / Total Stockholder Equity 4.42b)
RoCE = 23.77% (EBIT 2.21b / Capital Employed (Equity 4.42b + L.T.Debt 4.88b))
RoIC = 15.22% (NOPAT 1.62b / Invested Capital 10.62b)
WACC = 6.77% (E(25.50b)/V(32.54b) * Re(8.47%) + D(7.04b)/V(32.54b) * Rd(0.86%) * (1-Tc(0.27)))
Discount Rate = 8.47% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.16%
[DCF Debug] Terminal Value 84.25% ; FCFF base≈1.60b ; Y1≈1.82b ; Y5≈2.50b
Fair Price DCF = 169.1 (EV 56.83b - Net Debt 3.64b = Equity 53.19b / Shares 314.6m; r=6.77% [WACC]; 5y FCF grow 16.14% → 2.90% )
EPS Correlation: -20.44 | EPS CAGR: -43.62% | SUE: -4.0 | # QB: 0
Revenue Correlation: 60.62 | Revenue CAGR: 1.23% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.77 | Chg30d=-0.000 | Revisions Net=+1 | Analysts=4
EPS next Year (2026-12-31): EPS=9.93 | Chg30d=+0.178 | Revisions Net=-1 | Growth EPS=+18.4% | Growth Revenue=-0.7%